All Season Financial Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

All Season Financial Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,678	Closed	-$334K	–	112
2024 Q1	$334K	Buy	+3,678	New	+$322K	0.28%	93
2022 Q1	–	Sell	-5,184	Closed	-$399K	–	167
2021 Q4	$399K	Sell	5,184 -123	-2%	-$9.15K	0.28%	82
2021 Q3	$386K	Sell	5,307 -236	-4%	-$17.6K	0.31%	77
2021 Q2	$405K	Buy	+5,543	New	+$395K	0.29%	70

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

FPGK

Financial Partners Group (Kansas) Overland Park, Kansas $836M AUM 21.04% 1-Year Est. Return

All Season Financial Advisors's PPH Position: Q2 2024 in Review

All Season Financial Advisors sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2024, closing a stake of 3,678 shares — an estimated $334K sold.

All Season Financial Advisors first reported a position in PPH in Q2 2021 and held it in 4 quarters. The position peaked at $405K in Q2 2021. 140 funds tracked by Wall St. Rank hold PPH as of Q2 2024.

All Season Financial Advisors reported no remaining VanEck Pharmaceutical ETF position as of Q2 2024 after selling out during the quarter.
All Season Financial Advisors sold 3,678 VanEck Pharmaceutical ETF shares in Q2 2024, an estimated $334K.
All Season Financial Advisors first reported a position in VanEck Pharmaceutical ETF in Q2 2021 and held it in 4 quarters.
All Season Financial Advisors's VanEck Pharmaceutical ETF position peaked at $405K in Q2 2021.
140 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2024.

Based on All Season Financial Advisors's 13F filing for Q2 2024, filed 23 Jul 2024.